WHO ICTRP trial

Clinical study on TESTODAAT�® in male subjects during resistance training

CTRI/2021/07/034548 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/07/034548
Public title Clinical study on TESTODAAT�® in male subjects during resistance training
Scientific title Evaluation of Efficacy and Safety of TESTODAATÃ?® in Male Subjects during resistance training ââ?¬â?? A Randomized, Double Blind, Placebo Controlled, multi-centre, Comparative, interventional, Prospective Study - NIL
Primary sponsor LODAAT PHARMA
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Interventions Intervention1: TESTODAATÃ?® Capsule: TESTODAATÃ?® Contains Fenugreek seeds Extract (Trigonella foenum-graecum) ââ?¬â?? 275 mg Dosage and Treatment Duration: As per computer generated randomization list, subjects will be randomized either…
Registration date Feb 7, 2021
Target size 40
Secondary IDs TESTO/SPORT/LODAAT/2021/1, Version 1.0, 16th June 2021
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations